DB
OSCR icon

Dmitry Balyasny’s Oscar Health OSCR Stock Holding History

Dmitry Balyasny’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2M Buy
708,669
+414,498
+141% +$8.92M 0.03% 709
2026
Q1 		$3.37M Sell
294,171
-46,264
-14% -$652K ﹤0.01% 1542
2025
Q4 		$4.89M Sell
340,435
-247,190
-42% -$4.28M 0.01% 1410
2025
Q3 		$11.1M Buy
+587,625
New +$9.68M 0.01% 997
2025
Q1 		– Sell
-148,211
Closed -$1.99M – 3162
2024
Q4 		$1.99M Buy
+148,211
New +$2.39M ﹤0.01% 1672
2024
Q1 		– Sell
-68,816
Closed -$630K – 2972
2023
Q4 		$630K Sell
68,816
-827,793
-92% -$5.71M ﹤0.01% 1856
2023
Q3 		$4.99M Buy
896,609
+679,747
+313% +$4.76M 0.01% 1109
2023
Q2 		$1.75M Sell
216,862
-1,824,304
-89% -$13.5M ﹤0.01% 1422
2023
Q1 		$13.3M Buy
+2,041,166
New +$8.33M 0.03% 669
2022
Q2 		– Sell
-62,890
Closed -$627K – 3057
2022
Q1 		$627K Buy
62,890
+36,548
+139% +$272K ﹤0.01% 1761
2021
Q4 		$207K Buy
+26,342
New +$331K ﹤0.01% 1840

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dmitry Balyasny's OSCR Position: Q2 2026 in Review

Dmitry Balyasny increased its Oscar Health (OSCR) stake by 141% in Q2 2026, buying an estimated $8.92M and bringing the position to 708,669 shares worth $20.2M. The position accounts for 0.03% of the portfolio, ranked #709.

Dmitry Balyasny first reported a position in OSCR in Q4 2021 and has held it in 11 quarters since. 401 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Dmitry Balyasny held 708,669 shares of Oscar Health worth $20.2M as of Q2 2026.
  • Dmitry Balyasny bought 414,498 Oscar Health shares in Q2 2026, an estimated $8.92M.
  • Oscar Health made up 0.03% of Dmitry Balyasny's portfolio in Q2 2026, its #709 holding.
  • Dmitry Balyasny first reported a position in Oscar Health in Q4 2021 and has held it in 11 quarters since.
  • 401 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.